Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Study of HRS-8829 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial to assess safety, tolerability and pharmacokinetics of HRS-8829 in acute ischemic stroke; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• HRS-8829

Snippet

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd | Conditions: Acute Ischemia Stroke | Phase 1 | Status: NOT_YET_RECRUITING